Neogen Total Assets 2006-2020 | NEOG

Neogen total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Neogen Annual Total Assets
(Millions of US $)
2019 $696
2018 $618
2017 $528
2016 $450
2015 $392
2014 $345
2013 $291
2012 $252
2011 $220
2010 $180
2009 $142
2008 $126
2007 $105
2006 $88
2005 $64
Neogen Quarterly Total Assets
(Millions of US $)
2020-02-29 $774
2019-11-30 $751
2019-08-31 $721
2019-05-31 $696
2019-02-28 $673
2018-11-30 $660
2018-08-31 $641
2018-05-31 $618
2018-02-28 $596
2017-11-30 $581
2017-08-31 $547
2017-05-31 $528
2017-02-28 $507
2016-11-30 $487
2016-08-31 $469
2016-05-31 $450
2016-02-29 $432
2015-11-30 $426
2015-08-31 $409
2015-05-31 $392
2015-02-28 $378
2014-11-30 $366
2014-08-31 $358
2014-05-31 $345
2014-02-28 $330
2013-11-30 $320
2013-08-31 $308
2013-05-31 $291
2013-02-28 $281
2012-11-30 $270
2012-08-31 $261
2012-05-31 $252
2012-02-29 $240
2011-11-30 $234
2011-08-31 $228
2011-05-31 $220
2011-02-28 $209
2010-11-30 $204
2010-08-31 $191
2010-05-31 $180
2010-02-28 $165
2009-11-30 $161
2009-08-31 $152
2009-05-31 $142
2009-02-28 $140
2008-11-30 $137
2008-08-31 $133
2008-05-31 $126
2008-02-29 $120
2007-11-30 $115
2007-08-31 $109
2007-05-31 $105
2007-02-28 $100
2006-11-30 $98
2006-08-31 $94
2006-05-31 $88
2006-02-28 $86
2005-11-30 $69
2005-08-31 $68
2005-05-31 $64
2005-02-28 $63
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.079B $0.414B
Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company's Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen's is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $165.688B 28.73
Medtronic (MDT) Ireland $120.891B 19.64
Stryker (SYK) United States $66.633B 21.63
Boston Scientific (BSX) United States $48.278B 22.70
Baxter (BAX) United States $43.462B 26.53
Lonza Group Ag (LZAGY) Switzerland $42.008B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.981B 0.00
Terumo (TRUMY) Japan $28.231B 36.09
ResMed (RMD) United States $28.021B 44.22
Zimmer Biomet Holdings (ZBH) United States $24.281B 15.28
Sunny Optical Technology (SNPTF) China $20.840B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.828B 0.00
Bio-Rad Laboratories (BIO) United States $14.172B 64.51
Insulet (PODD) United States $13.329B 1320.56
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.288B 80.85
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
GN STORE NORD (GNNDY) Denmark $7.676B 39.13
Perrigo (PRGO) Ireland $7.396B 13.23
Hill-Rom Holdings (HRC) United States $7.394B 20.84
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.620B 0.00
Haemonetics (HAE) United States $4.381B 26.31
GW Pharmaceuticals (GWPH) United Kingdom $3.977B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
ICU Medical (ICUI) United States $3.761B 27.44
Agios Pharmaceuticals (AGIO) United States $3.676B 0.00
Envista Holdings (NVST) United States $3.138B 0.00
NuVasive (NUVA) United States $2.743B 22.03
TG Therapeutics (TGTX) United States $2.661B 0.00
National Vision Holdings (EYE) United States $2.237B 38.71
AtriCure (ATRC) United States $1.768B 0.00
MacroGenics (MGNX) United States $1.508B 0.00
NanoString Technologies (NSTG) United States $1.361B 0.00
Aurora Cannabis (ACB) Canada $1.333B 0.00
Aphria (APHA) Canada $1.206B 0.00
Cerus (CERS) United States $1.148B 0.00
Meridian Bioscience (VIVO) United States $1.069B 40.24
Cardiovascular Systems (CSII) United States $1.042B 0.00
Vapotherm (VAPO) United States $1.014B 0.00
Phibro Animal Health (PAHC) United States $0.996B 19.85
PetIQ (PETQ) United States $0.961B 27.75
DFB Healthcare Acquisitions (AHCO) United States $0.890B 148.08
OraSure Technologies (OSUR) United States $0.860B 173.13
Zynex (ZYXI) United States $0.853B 85.70
InMode (INMD) Israel $0.853B 18.02
Quanterix (QTRX) United States $0.779B 0.00
Omeros (OMER) United States $0.731B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.646B 46.29
BioLife Solutions (BLFS) United States $0.572B 162.82
VAREX IMAGING (VREX) United States $0.571B 14.18
Lantheus Holdings (LNTH) United States $0.571B 11.49
Surmodics (SRDX) United States $0.562B 67.75
LeMaitre Vascular (LMAT) United States $0.521B 29.67
Owens & Minor (OMI) United States $0.466B 12.33
Viemed Healthcare (VMD) United States $0.413B 36.62
Cytosorbents (CTSO) United States $0.368B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.328B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.90
Organigram Holdings (OGI) Canada $0.262B 0.00
InfuSystems Holdings (INFU) United States $0.224B 124.11
Female Health (VERU) United States $0.209B 0.00
Chimerix (CMRX) United States $0.192B 0.00
Surface Oncology (SURF) United States $0.161B 0.00
Bovie Medical (APYX) United States $0.158B 0.00
Fonar (FONR) United States $0.134B 11.83
Exagen (XGN) United States $0.133B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
United Health Products (UEEC) United States $0.117B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.108B 0.00
Wound Management Technologies (SMTI) United States $0.104B 0.00
Evolus (EOLS) United States $0.102B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Chembio Diagnostics (CEMI) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Nephros (NEPH) United States $0.068B 0.00
United-Guardian (UG) United States $0.066B 15.32
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00